期刊文献+

Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer 被引量:8

Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer
下载PDF
导出
摘要 Because of the intramural spread of gastric cancer,a sufficient length of a resection margin has to be attained to ensure complete excision of the tumor.There has been debate on an adequate length of proximal resection margin(PRM) and its related issues.Thus,the objective of this article is to review several studies on PRM and to summarize the current evidence on the subject.Although there is some discrepancy in the recommended values for PRM between authors,a PRM of more than 2-3 cm for early gastric cancer and 5-6 cm for advanced gastric cancer is thought to be acceptable.Once the margin is confirmed to be clear,however,the length of PRM measured in postoperative pathologic examination does not affect the patient's survival,even when it is shorter than the recommended values.Hence,the recommendations for PRM length should be applied only to intraoperative decision-making to prevent positive margins on the final pathology.Given that a negative resection margin is the ultimate goal of determining an adequate PRM,development and improvement of reliable methods to confirm a negative resection margin intraoperatively would minimize the extent of surgery and offer a better quality of life to more patients.In the same context,special attention has to be paid to patients who have advanced stage or diffuse-type gastric cancer,because they are more likely to have a positive margin.Therefore,a wider excision with intraoperative frozen section(IFS) examination of the resection margin is necessary.Despite all the attempts to avoid positive margins,there is still a certain rate of positive-margin cases.Since the negative impact of a positive margin on prognosis is mostly obvious in low N stage patients,aggressive further management,such as extensive re-operation,is required for these patients.In conclusion,every possible preoperative and intraoperative evaluation should be thoroughly carried out to identify in advance the patients with a high risk of having positive margins;these patients need careful management with a wider excision or an IFS examination to confirm a negative margin during surgery. Because of the intramural spread of gastric cancer,a sufficient length of a resection margin has to be attained to ensure complete excision of the tumor.There has been debate on an adequate length of proximal resection margin(PRM) and its related issues.Thus,the objective of this article is to review several studies on PRM and to summarize the current evidence on the subject.Although there is some discrepancy in the recommended values for PRM between authors,a PRM of more than 2-3 cm for early gastric cancer and 5-6 cm for advanced gastric cancer is thought to be acceptable.Once the margin is confirmed to be clear,however,the length of PRM measured in postoperative pathologic examination does not affect the patient’s survival,even when it is shorter than the recommended values.Hence,the recommendations for PRM length should be applied only to intraoperative decision-making to prevent positive margins on the final pathology.Given that a negative resection margin is the ultimate goal of determining an adequate PRM,development and improvement of reliable methods to confirm a negative resection margin intraoperatively would minimize the extent of surgery and offer a better quality of life to more patients.In the same context,special attention has to be paid to patients who have advanced stage or diffuse-type gastric cancer,because they are more likely to have a positive margin.Therefore,a wider excision with intraoperative frozen section(IFS) examination of the resection margin is necessary.Despite all the attempts to avoid positive margins,there is still a certain rate of positive-margin cases.Since the negative impact of a positive margin on prognosis is mostly obvious in low N stage patients,aggressive further management,such as extensive re-operation,is required for these patients.In conclusion,every possible preoperative and intraoperative evaluation should be thoroughly carried out to identify in advance the patients with a high risk of having positive margins;these patients need careful management with a wider excision or an IFS examination to confirm a negative margin during surgery.
出处 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2013年第1期4-11,共8页 世界胃肠肿瘤学杂志(英文版)(电子版)
基金 Supported by National Research Foundation of Korea Grant funded by the Korean Government,No. 2010-0024825
关键词 RESECTION MARGIN PROXIMAL RESECTION MARGIN Negative RESECTION MARGIN Positive RESECTION MARGIN GASTRECTOMY GASTRIC cancer Resection margin Proximal resection margin Negative resection margin Positive resection margin Gastrectomy Gastric cancer
  • 相关文献

参考文献50

  • 1Hamid Reza Raziee,Roberta Cardoso,Rajini Seevaratnam,Alyson Mahar,Lucy Helyer,Calvin Law,Natalie Coburn.Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival[J]. Gastric Cancer . 2012 (1)
  • 2Shang-Yu Wang MD,Chun-Nan Yeh MD,Hsiang-Lin Lee MD,Yu-Yin Liu MD,Tzu-Chieh Chao MD, PhD,Tsann-Long Hwang MD, FACS,Yi-Yin Jan MD, FACS,Miin-Fu Chen MD, FACS.Clinical Impact of Positive Surgical Margin Status on Gastric Cancer Patients Undergoing Gastrectomy[J]. Annals of Surgical Oncology . 2009 (10)
  • 3P. Morgagni,D. Garcea,D. Marrelli,G. Manzoni,G. Natalini,H. Kurihara,A. Marchet,L. Saragoni,E. Scarpi,C. Pedrazzani,A. Di Leo,F. Santis,V. Panizzo,D. Nitti,F. Roviello.Resection Line Involvement After Gastric Cancer Surgery: Clinical Outcome in Nonsurgically Retreated Patients[J]. World Journal of Surgery . 2008 (12)
  • 4Jong Han Kim MD,Sung Soo Park MD,Jin Kim MD,Yoon Jung Boo MD,Seung Joo Kim MD,Young Jae Mok MD,Chong Suk Kim MD, PhD.Surgical Outcomes for Gastric Cancer in the Upper Third of the Stomach[J]. World Journal of Surgery . 2006 (10)
  • 5Paolo Morgagni MD,Domenico Garcea MD,Daniele Marrelli MD,Giovanni Manzoni MD,Giovanni Natalini MD,Hayato Kurihara MD,Alberto Marchet MD,Giovanni Vittimberga MD,Luca Saragoni MD,Franco Roviello MD,Alberto Di Leo MD,Francesco Santis MD,Valerio Panizza MD,Donato Nitti MD.Does Resection Line Involvement Affect Prognosis in Early Gastric Cancer Patients? An Italian Multicentric Study[J]. World Journal of Surgery . 2006 (4)
  • 6Steven C. Cunningham M.D.,Farin Kamangar M.D., M.P.H.,Min P. Kim M.D.,Sommer Hammoud,Raqeeb Haque,Anirban Maitra M.B.B.S.,Elizabeth Montgomery M.D.,Richard E. Heitmiller M.D., F.A.C.S.,Michael A. Choti M.D., F.A.C.S.,Keith D. Lillemoe M.D., F.A.C.S.,John L. Cameron M.D., F.A.C.S., F.R.C.S.(Eng.) (hon), F.R.C.S.I. (hon),Charles J. Yeo M.D., F.A.C.S.,Richard D. Schulick M.D., F.A.C.S..Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution[J]. Journal of Gastrointestinal Surgery . 2005 (5)
  • 7B. J. Dicken MD,L. D. Saunders PhD,G. S. Jhangri MSc,C. Gara FRCSC,C. Cass PhD,S. Andrews MD,S. M. Hamilton FRCSC.Gastric Cancer: Establishing Predictors of Biologic Behavior with Use of Population-Based Data[J]. Annals of Surgical Oncology . 2004 (6)
  • 8Satoshi Matsusaka M.D., Ph.D.,Tomohumi Nagareda M.D., Ph.D.,Hajime Yamasaki M.D., Ph.D.,Yoshihiro Kitayama M.D., Ph.D.,Toshihiro Okada M.D.,Shigeto Maeda M.D..Immunohistochemical Evaluation for Intraoperative Rapid Pathological Assessment of the Gastric Margin[J]. World Journal of Surgery . 2003 (6)
  • 9Prudencio S. Samson,Laurence Anthony P. Escovidal,Samuel G. Yrastorza,Ronaldo G. Veneracion,Mary Yvonnette C. Nerves.Re-study of Gastric Cancer: Analysis of Outcome[J]. World Journal of Surgery . 2002 (4)
  • 10Yuichi Kasakura,Masashi Fujii,Fumiro Mochizuki,Shigeru Imai,Noriaki Kanamori,Tetsuro Suzuki.Clinicopathological features of the superficial spreading type of early gastric cancer[J]. Gastric Cancer . 1999 (2)

共引文献11

同被引文献33

  • 1Wei Li, Tian-Shu Liu,Jing Qin, Yi-Hong Sun.Neoadjuvant chemotherapy for advanced gastric cancer:A meta-analysis[J].World Journal of Gastroenterology,2010,16(44):5621-5628. 被引量:22
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:435
  • 3Ilfet Songun,Hein Putter,Elma Meershoek-Klein Kranenbarg,Mitsuru Sasako,Cornelis JH van de Velde.Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncology . 2010 (5)
  • 4Kay Washington MD, PhD.7th Edition of the AJCC Cancer Staging Manual: Stomach[J].Annals of Surgical Oncology.2010(12)
  • 5Songun I,Putter H,Kranenbarg E,张信华.胃癌外科治疗:荷兰全国随机D1与D2临床试验15年随访结果报告[J].消化肿瘤杂志(电子版).2010(01)
  • 6Yun-Suhk Suh,Dong-Seok Han,Seong-Ho Kong,Sebastianus Kwon,Cheong-Il Shin,Woo-Ho Kim,Hyung-Ho Kim,Hyuk-Joon Lee,Han-Kwang Yang.Laparoscopy-Assisted Pylorus-Preserving Gastrectomy Is Better Than Laparoscopy-Assisted Distal Gastrectomy for Middle-Third Early Gastric Cancer[J].Annals of Surgery.2014(3)
  • 7Maria C. Russell,Paul F. Mansfield.Surgical approaches to gastric cancer[J].J Surg Oncol.2012(3)
  • 8Takashi Fujimura,Sachio Fushida,Masato Kayahara,Tetsuo Ohta,Shinichi Kinami,Koichi Miwa.Transectional gastrectomy: An old but renewed concept for early gastric cancer[J].Surgery Today.2010(5)
  • 9You‐JinJang,Man‐SikPark,Jong‐HanKim,Sung‐SooPark,Seung‐HeumPark,Seung‐JooKim,Chong‐SukKim,Young‐JaeMok.Advanced gastric cancer in the middle one‐third of the stomach: Should surgenos perform total gastrectomy?[J].J Surg Oncol.2010(6)
  • 10Shang-Yu Wang MD,Chun-Nan Yeh MD,Hsiang-Lin Lee MD,Yu-Yin Liu MD,Tzu-Chieh Chao MD, PhD,Tsann-Long Hwang MD, FACS,Yi-Yin Jan MD, FACS,Miin-Fu Chen MD, FACS.Clinical Impact of Positive Surgical Margin Status on Gastric Cancer Patients Undergoing Gastrectomy[J].Annals of Surgical Oncology.2009(10)

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部